The Food & Drug Administration's recent approval of process analytical technology (PAT) for use in the pharmaceutical industry is being hailed by drug manufacturers because it encourages process ...

LONDON--(BUSINESS WIRE)--SpendEdge, a leading provider of procurement market intelligence solutions, has announced the completion of their latest article on improving efficiency in pharma ...

DynoChem Platform Designed to Facilitate API Process Development and Scale-up Already used by 11 of the world’s biggest pharmaceutical companies, the DynoChem (www.scale-up.com) platform was developed ...

Within pharmaceutical process development, chemicals previously synthesised at the milligram level require scaling up to gram levels and above. These are often novel chemicals or utilise large numbers ...

DUBLIN, Jan 12, 2012 (BUSINESS WIRE) -- Scale-up Systems Limited, the leading global supplier of process development software to the pharmaceutical industry, today announced that Dr Wilfried Hoffmann ...

Donna Conroy, MS is Founder/CEO of SciMar ONE, Inc. a technology company building AI-based SaaS solutions for the pharmaceutical industry. Investing time and resources is clearly a long-term strategy ...

LONDON--(BUSINESS WIRE)--The increasing competition of the pharmaceutical industry has encouraged companies to invest in innovation and drug development. However, the drug development process is ...

Variations on standard tablets, which can be distinguished by both colour and shape.— Photo by Ragesoss (CC BY-SA 2.0) Variations on standard tablets, which can be distinguished by both colour and ...

The patent covers intermediate compounds and processes for the preparation of Fingolimod NESS ZIONA, Israel, Feb 18, 2014 (BUSINESS WIRE) -- Mapi Pharma Ltd. ("Mapi" or the "Company"), a developer of ...

Capiton AG moved its portfolio company KD Pharma Group into a continuation fund for more time to manage the asset, the firm said Dec. 11. Pantheon and Aberdeen Standard Investments led the deal ...

LEEDS, England--(BUSINESS WIRE)-- 4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) - a novel class of drug derived from the microbiome ...